SNS Subscriber Edition • Volume 22, Issue 6 • Week of February 6, 2017


Augmenting Immunity II:

Autoimmune Diseases and Summary



SNS: Augmenting Immunity II:
Autoimmune Diseases and Summary


[Please open the attached .pdf for best viewing.]


 This Week's Favorite Book:

Sometimes Brilliant

by Larry Brilliant

In This Issue
Week of 2/6/2017    Vol. 24 Issue 6


Past FiRe participants will remember Larry Brilliant's many appearances onstage, as well as his combination of intellect with spiritual awareness. All of this is captured in his new book, which I highly recommend. - mra.



Augmenting Immunity II:
    Autoimmune Diseases and Summary

We've coined the term Augmented Immunity ("AugI") to address the patterns of effective discoveries deriving from treatments that collectively share the attributes of harnessing the patient's own immune system to combat disease. We've also coined the acronym TAR to describe the three primary aspects of augmented immunity successes: Target, Amplify, and Regulate.

In Part I, we described the overall approach under the category of AugI, and then focused on recent successes (and the companies behind them) in treating cancer. In Part II, we will shift to related work, still under AugI, in treating autoimmune diseases - a class that has essentially been considered incurable, at least until now.


Member's please login to view the complete newsletter >>


Buy a membership to view the whole issue >>

Share this: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone